E1A second exon requirements for induction of target cell susceptibility to lysis by natural killer cells: Implications for the mechanism of action

Virology

Volumn 217, Issue 1, 1996, Pages 23-32

  Krantz, Carol K ^a   Routes, Barbara A ^b   Quinlan, Margaret P ^c   Cook, James L ^a,b,d  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOLYSIS; EXON; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RAT;

ADENOVIRIDAE; ANIMALIA; CRICETINAE; HUMAN ADENOVIRUS TYPE 5; MAMMALIA;

EID: 0029963268     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0089     Document Type: Article

References (53)

1. Ames, R. S., Holskin, B., Mitcho, M., Shalloway, D., and Chen, M. (1990). Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation. J. Virol. 64, 4115-4122.
2. Bautista, D. S., Hitt, M., McGrory, J., and Graham, F. L. (1991). Isolation and characterization of insertion mutants in E1A of adenovirus type 5. Virology 182, 578-596.
3. Bellgrau, D., Walker, T. A., and Cook, J. L. (1988). Recognition of adenovirus E1A gene products on immortalized cell surfaces by cytotoxic T lymphocytes. J. Virol. 62(5), 1513-1519.
4. Bondesson, M., Svensson, C., Linder, S., and Akusjärvi, G. (1992). The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation. EMBO J. 11(9), 3347-3354.
5. Chadwick, B. S., Sambhara, S. R., Sasakura, Y., and Miller, R. G. (1992). Effect of class I MHC binding peptides on recognition by natural killer cells. J. Immunol. 149(10), 3150-3156.
6. Chen, M.-J., Holskin, B., Strickler, J., Gorniak, J., Clark, M. A., Johnson, P. J., Mitcho, M., and Shalloway, D. (1987). Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330, 581-583.
7. Chong, A. S.-F., Scuderi, P., Grimes, W. J., and Hresh, E. M. (1989). Tumour targets stimulate activated killer cells to produce interferon-gamma and tumour necrosis factor. J. Immunol. 142, 2133-2139.
8. Cook, J., Hauser, J., Patch, C., Lewis, A., Jr., and Levine, A. (1983). Adenovirus 2 early gene expression promotes susceptibility to effector cell lysis of hybrids formed between hamster cells transformed by adenovirus 2 and simian virus 40. Proc. Natl. Acad. Sci. USA 80, 5995-5999.
9. Cook, J. L., Hibbs, J. R., Jr., and Lewis, A. M., Jr. (1982). DNA virus-transformed hamster cell-host effector cell interactions: Level of resistance to cytolysis correlated with tumorigenicity. Int. J. Cancer 30, 795-803.
10. Cook, J. L., and Lewis, A. M. J. (1979). Host response to adenovirus 2 transformed hamster embryo cells. Cancer Res. 39, 1455-1461.
11. Cook, J. L., May, D. L., Lewis, A., Jr., and Walker, T. A. (1987). Adenovirus E1A gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells. J. Virol. 61(11), 3510-3520.
12. Cook, J. L., May, D. L., Wilson, B. A., Holskin, B., Chen, M.-J., Shalloway, D., and Walker, T. A. (1989a). Role of tumor necrosis factor-alpha in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages. J. Immunol. 142, 4527-4534.
13. Cook, J. L., May, D. L., Wilson, B. A., and Walker, T. A. (1989b). Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells. J. Virol. 63(8), 3408-3415.
14. Cook, J. L., Walker, T. A., Lewis, A. M., Jr., Ruley, H. E., Graham, F. L., and Pilder, S. H. (1986). Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Proc. Natl. Acad. Sci. USA 83, 6965-6969.
15. Cook, J. L., Wilson, B. A., Wolf, L. A., and Walker, T. A. (1993). E1A oncogene expression level in sarcoma cells: An independent determinant of cytolytic susceptibility and tumor rejection. Oncogene 8, 625-635.
16. Duerksen-Hughes, P., Wold, W. S. M., and Gooding, L. R. (1989). Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143, 4193-4200.
17. Franza, B. R., Maruyama, K., Garrels, J. I., and Ruley, H. E. (1986). In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell 44, 409-418.
18. Gallimore, P. H. (1974). Interactions of adenovirus type 2 with rat embryo cells; permissiveness, transformation and in vitro characteristics of adenovirus transformed rat embryo cells. J. Gen. Virol. 25, 263-273.
19. Germain, R. N., and Margulies, D. H. (1993). The biochemistry and cell biology of antigen processing and presentation. Ann. Rev. Immunol. 11, 403-451.
20. Haddada, H., Lewis, A. M., Jr., Sogn, J. A., Coligan, J. E., Cook, J. L., Walker, T. A., and Levine, A. S. (1986). Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class I major histocompatibility antigens expressed on the cells. Proc. Natl. Acad. Sci. USA 83, 9684-9688.
21. Harlow, E., Franza, R., Jr., and Schley, C. (1985). Monoclonal antibodies specific for adenovirus early region 1A proteins: Extensive heterogeneity in early region 1A products. J. Virol. 55, 533-546.
22. Jones, N., and Shenk, T. (1979). Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17(3), 683-689.
23. Karrë, K. (1985). Role of target histocompatibility antigens in regulation of natural killer activity: A reevaluation and a hypothesis. In "Mechanisms of Cytotoxicity by NK Cells" (R B. Herberman and D. M. Callewaert, Eds.), pp. 81-92. Academic Press, New York.
24. Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., van der Eb, A. J., and Melief, C. J. M. (1989). Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59, 603-614.
25. Kelekar, A., and Cole, M. D. (1987). Immortalization by c-myc, H-ras, and E1a oncogenes induces differential cellular gene expression and growth factor responses. Mol. Cell. Biol. 7, 3899-3907.
26. Kingston, R. E., Baldwin, A. S., and Sharp, P. A. (1985). Transcription control by oncogenes. Cell 41, 3-5.
27. Kurosawa, S., Matsuzaki, G., Harada, M., Ando, T., and Nomoto, K. (1993). Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development. Eur. J. Immunol. 23, 1029-1033.
28. Lewis, A. M. J., and Cook, J. L. (1985). A new role for DNA virus early proteins in viral carcinogenesis. Science 227, 15-20.
29. Linder, S., Przemyslaw, P., Svensson, C., Marshall, H., Bondesson, M., and Akusjarvi, G. (1992). Enhanced invasive properties of rat embryo fibroblasts transformed by adenovirus E1A mutants with deletions in the carboxy-terminal exon. Oncogene 7, 439-443.
30. Ljunggren, H.-G., and Karrë, K. (1990). In search of the 'missing self: MHC molecules and NK recognition. Immunol. Today 11, 237-244.
31. Moran, E., Grodzicker, T., Roberts, R. J., Mathews, M. B., and Zerler, B. (1986). Lytic and transforming functions of individual products of the adenovirus E1A gene. J. Virol. 57, 765-775.
32. Mymryk, J. S., and Bayley, S. T. (1993). Induction of gene expression by exon 2 of the major E1A proteins of adenovirus type 5. J. Virol. 67, 6922-6928.
33. Ortaldo, J. R. (1986). Comparison of natural killer and natural cytotoxic cells: Characteristics, regulation, and mechanism of action. Pathol. Immunopathol. Res. 5, 203-218.
34. Ortaldo, J. R. (1989). Cytokine production by CD3-large granular lymphocytes. In "Functions of the Natural Immune System" (C. W. Reynolds and R. H. Wiltrout, Eds.), pp. 299-311. Plenum, New York.
35. Quinlan, M. P., Whyte, P., and Grodzicker, T. (1988). Growth factor induction by the adenovirus type 5 E1A 12S protein is required for immortalization of primary epithelial cells. Mol. Cell. Biol. 8(8), 3191-3203.
36. Raska, K., Jr., and Gallimore, P. H. (1982). An inverse correlation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123, 8-18.
37. Routes, J. M., Bellgrau, D., McGrory, W. J., Bautista, D. S., Graham, F. L., and Cook, J. L. (1991). Anti-adenovirus type 5 cytotoxicTlymphocytes: Immunodominant epitopes are encoded by the E1A gene. J. Virol. 65(3), 1450-1457.
38. Routes, J. M., and Cook, J. L. (1990). Resistance of human cells to the adenovirus E3 effect on class I MHC antigen expression: Implications for antiviral immunity. J. Immunol. 144, 2763-2770.
39. Routes, J. M., and Cook, J. L. (1995). E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells. Virology 210, 421-428.
40. Sawada, Y., Fohring, B., Shenk, T. E., and Raska, K., Jr. (1985). Tumorigenicity of adenovirus-transformed cells: Region E1A of adenovirus 12 confers resistance to natural killer cells. Virology 147, 413-421.
41. Schneider, J. F., Fisher, F., Goding, C. R., and Janes, N. C. (1987). Mutational analysis of the adenovirus E1a gene: The role of transcriptional regulation in transformation. EMBO J. 6, 2053-2060.
42. Sentman, C. L., Olsson, M. Y., Salcedo, M., Höglund, P., Lendahl, U., and Kärre, K. (1994). H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by α1/α2 domains. J. Immunol. 153, 5482-5490.
43. Shell, J. M., Gallimore, P. H., Zimmer, S. G., and Sopori, M. L. (1984). Susceptibility of adenovirus 2-transformed rat cell lines to natural killer (NK) cells: Direct correlation between NK resistance and in vivo tumorigenesis. J. Immunol. 132, 1578-1582.
44. Solnick, D. (1981). An adenovirus mutant defective in splicing RNA from early region 1A. Nature 291, 503.
45. Storkus, W. J., Alexander, J., Payne, J. A., Cresswell, P., and Dawson, J. R. (1989). The α1/α2 domains of class I HLA molecules confer resistance to natural killing. J. Immunol. 143(11), 3853-3857.
46. Storkus, W. J., and Dawson, J. R. (1991). Target structures involved in natural killing (NK): Characteristics, distribution, and candidate molecules. Crit. Rev. Immunol. 10(5), 393-416.
47. Storkus, W. J., Salter, R. D., Cresswell, P., and Dawson, J. R. (1992). Peptide-induced modulation of target cell sensitivity to natural killing. J. Immunol. 149(4), 1185-1190.
48. Tsuji, Y., Ninomiya-Tsuji, J., Torti, S. V., and Torti, F. M. (1993). Augmentation by IL-Iα of tumor necrosis factor-a cytotoxicity in cells transfected with adenovirus E1A. J. Immunol. 150(5), 1897-1907.
49. van Dam, H., Offringa, R., Smits, A. M., Bos, J. L., Jones, N. C., and van der Eb, A. J. (1989). The repression of the growth factor-inducible genes JE, c-myc, and stromelysin by adenovirus E1A is mediated by conserved region 1. Oncogene 4, 1207-1212.
50. Velcich, A., and Ziff, E. (1988). Adenovirus E1a ras cooperation activity is separate from its positive and negative transcription regulatory functions. Mol. Cell. Biol. 8(5), 2177-2183.
51. Walker, T. A., Wilson, B. A., Lewis, A. M., Jr., and Cook, J. L. (1991). E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity. Proc. Natl. Acad. Sci. USA 88, 6491-6495.
52. Yokoyama, W. M. (1995). Natural killer cell receptors. Curr. Opin. Immunol. 7, 110-120.
53. Zerler, B., Moran, B., Maruyama, K., Moomaw, J., Grodzicker, T., and Ruley, H. E. (1986). Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells. Mol. Cell. Biol. 6, 887-899.